EL.En Past Earnings Performance

Past criteria checks 3/6

EL.En has been growing earnings at an average annual rate of 16.8%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 13.6% per year. EL.En's return on equity is 13.7%, and it has net margins of 7.7%.

Key information

16.8%

Earnings growth rate

18.8%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate13.6%
Return on equity13.7%
Net Margin7.7%
Next Earnings Update13 Mar 2025

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown

How EL.En makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:ELNM Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24666511700
30 Jun 24660491690
31 Mar 24680461700
31 Dec 23692481670
30 Sep 23682481650
30 Jun 23692651630
31 Mar 23691541570
31 Dec 22674551520
30 Sep 22650581490
30 Jun 22624511470
31 Mar 22599491390
31 Dec 21571451320
30 Sep 21545491270
30 Jun 21519361160
31 Mar 21452301040
31 Dec 20408201010
30 Sep 20387151000
30 Jun 20375221010
31 Mar 20391241090
31 Dec 19401261100
30 Sep 19377321050
30 Jun 19377201060
31 Mar 19364191040
31 Dec 18350171020
30 Jun 1832717960
31 Mar 1830717920
31 Dec 1730916910
30 Jun 1727716840
31 Mar 1726628810
31 Dec 1625540780
30 Jun 1623337730
31 Mar 1622626720
31 Dec 1521914710
30 Sep 1521415700
30 Jun 1520816680
31 Mar 1519516660
31 Dec 1418117640
30 Sep 1417315630
30 Jun 1416513610
31 Mar 1416210610
31 Dec 131596610

Quality Earnings: ELNM has high quality earnings.

Growing Profit Margin: ELNM's current net profit margins (7.7%) are higher than last year (7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ELNM's earnings have grown by 16.8% per year over the past 5 years.

Accelerating Growth: ELNM's earnings growth over the past year (6.5%) is below its 5-year average (16.8% per year).

Earnings vs Industry: ELNM earnings growth over the past year (6.5%) did not outperform the Medical Equipment industry 39.9%.


Return on Equity

High ROE: ELNM's Return on Equity (13.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 13:47
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EL.En. S.p.A. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fabrizio SpagnaAxia Financial Research
Andrea BonfaBanca Akros S.p.A. (ESN)
Gustav FrobergBerenberg